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Abstract 
Objective: Active and passive smoking lead to the production of a number of oxidants and 
antioxidants with various adverse health effects compromising the immune system. Tobacco use 
increases the production of free radicals as well. The purpose of this study was to determine the 
effects of passive smoking on total antioxidant capacity (TAC) of serum and saliva in rats. 
Methods: This experimental study was conducted on 18 rats with an age range of 7-11 weeks 
weighing 160-200 g; 9 of them were exposed to cigarette smoke 3 times daily for 8 minutes. The 9 
controls were not exposed to cigarette smoke. After injection of 0.2 mg/kg midazolam and 0.5  
mg/kg pilocarpine, serum and saliva samples were taken from subjects in the exposure and control 
groups at 0, 15 and 30 days. Serum cotinine was measured using ELISA kit. TAC of saliva and 
serum was measured using ferric reducing antioxidant power (FRAP) assay. TAC values at different 
time points were statistically analyzed in each group using Repeated Measures ANOVA and 
compared between the two groups using t-test. 
Results: At baseline, no significant difference existed between the two groups in terms of serum 
cotinine concentration but at days 15 and 30, cotinine serum concentration significantly increased in 
the exposure group. At baseline and 30 days, no significant difference existed between the two 
groups of passive smoker and non-smoker in terms of serum TAC values but at day 15, serum TAC 
values were significantly higher in the exposure group. Also, TAC of salivawas significantly higher 
in the passive smoker group at baseline and at day 15 but at day 30, the difference in this respect 
between the two groups was not statistically significant. 
Conclusion: Based on the obtained results, changes in TAC of serum and saliva in rats due to 
exposure to cigarette smoke were compensated by their immune system activity. However, further 
investigations are still required in this respect. 
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Passive smoking or passive inhalation of 
cigarette smoke in public places is a public 
health hazard. It is estimated that at least one 
billion adults are addicted to tobacco use 
worldwide  and  at  least  700  million    children 
breathe in cigarette smoke-polluted air (1, 2). 
Exposure to cigarette smoke is almost inevitable 
since adults smoke in areas where children live 
or play (2, 3). Children are particularly more 
susceptible to passive smoking because they 
have smaller airways and their immune system 
has yet to be fully developed (4). Free radicals 
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are unwanted molecules that are physiologically 
produced in an organism. In some cases, their 
production increases as the result of active or 
passive smoking. It has been revealed that one 
puff of cigarette approximately produces 1,014 
free radicals (5). 
Cigarette smoke contains numerous (more than 
4000) chemical compounds that spread in the 
form of gas. Many of these compounds are 
oxidants and pro-oxidants and are capable of 
producing various oxygen species (6). Increased 
production of reactive oxygen species due to 
tobacco use can lead to oxidative stress and 
result in lipid oxidation, DNA break down, 
inactivation of specific proteins and 
disintegration of biologic membranes (7, 8). 
Increased oxidative stress plays a critical role in 
the pathogenesis of some smoking-related 
diseases such as cancer, cardiovascular diseases 
and oral pathologies (9-11). 
In order to fight oxidants, anti-oxidant 
mechanisms exist through which, antioxidant 
molecules inhibit the harmful reactions caused  
by oxidative stress (12). However, in some cases 
oxidants increase and antioxidants decease or 
antioxidant mechanisms are not sufficient to 
completely prevent the damage caused by 
oxidants. Based on the available evidence, 
smoking is associated with an increase in free 
radicals, oxidative stress and antioxidant 
depletion (13). Oxidative stress is involved in 
etiopathogenesis of about 100 different diseases 
(14). Also, cigarette smoking decreases serum 
TAC and this reduction initiates oral 
inflammatory diseases, promotes precancerous 
transformations and destroys homeostasis of oral 
cavity (15). 
Several methods are available for the 
measurement of exposure to passive smoke. 
Although serum or plasma concentration of 
different antioxidants can be separately 
measured in the laboratories, these  
measurements are very expensive and time 
consuming  and  require  the  use  of     advanced 
 
techniques. Saliva is a relatively thick fluid that 
protects the oral cavity. Its constituents include 
enzymatic and non-enzymatic proteins, calcium, 
phosphorus, sodium, other salts, dissolved gases 
such as nitrogen, oxygen and carbon dioxide and 
cells (16). Salivary cotinine is also a product of 
decomposition of nicotine with a half-life of  
20h. It is stable against thermal changes or 
infection. Furthermore, it has higher sensitivity 
and specificity for the measurement of exposure 
to passive smokecompared to nicotine (17). 
Determining the salivary cotinine concentration 
is a suitable method for the measurement of 
exposure to passive smoke because its collection 
is easy, its half-life is longer than the plasma 
nicotine and has specific properties against 
tobacco (2, 18). 
Considering the growing use of cigarette and 
tobacco products, a large number of children are 
inadvertently exposed to cigarette smoke. It is 
particularly important to find out whether 
passive smoking has the same effects as active 
smoking or not. Thus, the present study aimed to 
determine the effect of passive smoking on TAC 




This experimental animal model study was 
conducted on 20 rats that were divided into two 
groups of 10. During the first 15 days, one 
animal in the exposure group died. Thus, one rat 
was also excluded from the control group. The 
study was continued on 2 groups of 9. The rats 
were in the age range of 7-11 weeks and 
weighed 160-200 g. The rats were all males and 
of Albino race. Animals were kept under similar 
conditions at 22±1°C temperature and shared the 
same food and water source. At day 0 (baseline), 
0.2 mg/kg midazolam and 0.5 mg/kg pilocarpine 
were administered and blood and saliva samples 
were obtained (blood sample was taken from the 
rats’ corner of eyes). From the next day on, rats 
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smoke of 10 cigarettes (Winston with 
nicotine=13 and tar=1mg) 3 times a day (8 a.m., 
12 p.m. and 4 p.m.) for 8 minutes. Control rats at 
the mentioned time points were only transferred 
to another box with no exposure to cigarette 
smoke. Rats in the exposure group were placed 
in a box specifically designed for this purpose. 
After the injection of midazolam and  
pilocarpine, serum and saliva samples were 
obtained at 0, 15 and 30 days and the animals 
were sacrificed afterwards. Blood samples after 
each time of collection were centrifuged at 3000 
rpm and serum and saliva samples were stored in 
a  freezer.  After  centrifugation,  the supernatant 
 
was transferred to a test tube with a pipette and 
serum cotinine level was measured using ELISA 
kit (rat cotinine ELISA kit, Calbiotech Inc.,). 
This way we ensured the exposure to cigarette 
smoke in rats in the exposure group and no 
exposure in the control group. Next, FRAP assay 
was carried out on serum and saliva samples and 
the reduction of a ferric 2,4,6-tripyridyl-s  
triazine complex (Fe3+-TPTZ) by antioxidants  
to ferrous form was assessed using 
spectrophotometry at 593  nm  wavelength 
against standard FeSO4 to measure TAC of  



















2 5 9 
Figure 1- 1. Room for placement of rats, 2. Location of cigarettes, 3. Smoke accumulation area, 4. Air exit 
way, 5.Valve for the exit of excess smoke, 6. Holes to allow transfer of smoke from the smoke container to the 
rats container, 7. Pipe passing the smoke from the engine to the upper compartment, 8. Tube suctioning the 




The FRAP assay was carried out according to  
the method described by Benzie and Strain 
(1996)(19). This assay is based on the reduction 
of a ferric 2,4,6-tripyridyl-s triazine complex 
(Fe3+-TPTZ) by antioxidants to ferrous form at 
low pH.As a result, ferrous tri-pyridyl-triazine 
complex is produced in presence of antioxidants; 
which is acolored product. FRAP reagent 
containing  10  mM  TPTZ  (Merck)  in  40  mM 
hydrochloric acid, 20 mM FeCl3 (Merck) and 
300 mM/lit acetate buffer in 10:1:1 ratio was 
prepared for the assay. FRAP values were 
obtained by the comparison of absorbance 
changes at 593 nm between the understudy 
specimen and the standards containing ferrous 
ions in specific amounts. The standards used 
contained FeSO4 (Merck) at different 
concentrations (125, 250, 500 and 1000 mM). A 
total of 1.5 ml of a freshly prepared FRAP 
solution  with  1:1:10  ratio  of  acetate     buffer, 
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FeCl3 and TPTZ reagent was poured into the  
test tubes and placed in a bain-marie at 37˚C for 
5 min. Afterwards, 50 µl of the specimen was 
added to the tube and stored in a bain-marie at 
37˚C for 10 min. Absorbance values were read  
at 593 nm with an spectrophotometer versus a 
blank reading (1.5 ml FRAP and 50 µl distilled 
water). Finally, by using standard samples and 
drawing a standard chart, antioxidant 
concentration of understudy specimens was 
calculated. Measurements were done in  
triplicate. 
Repeated Measures ANOVA was used to 
evaluate changes in understudy parameters at 
different time points in each group. Independent 
t-test was applied to compare the parameters    at 
 




Serum cotinine concentration in the exposure 
and non-exposure groups at 0, 15 and 30 days is 
demonstrated in Table 1. ANOVA showed a 
significant increase in serum cotinine levels at 
different time points in the exposure group 
compared to the non-exposure group (both 
ps<0.0001). T-test showed that at baseline, no 
significant difference existed between the two 
groups in terms of cotinine concentration 
(p=0.693). But at days 15 (p<0.001) and 30 
(p<0.0001), cotinine concentration significantly 
increased in the exposure group (Table 1). 
 
Table 1. The mean and standard deviation of cotinine concentration in rats in the two groups of exposure and 
non-exposure at different time points. 
Group Day 0 Day 15 Day 30 P value* (intragroup) 










*Repeated Measures ANOVA 
**T-test 
 
Serum TAC in the two groups at different time 
points is demonstrated in Table 2. ANOVA 
showed a significant increase in serum TAC in 
the passive smoker group at allunderstudy time 
points (p<0.0001). But, the difference in serum 
TAC at the mentioned time points was not 
significant  in  the  non-smoker  group    (p=0.6). 
Furthermore, t-test revealed that no significant 
difference existed at baseline in serum TAC 
between the two groups of exposure and non- 
exposure but at day 15, TAC values significantly 
increased in the passive smoker group 
(p<0.0001)(Table 2). 
Table 2- The mean and standard deviation of serum TAC in rats in the two groups of passive smoker and 
non-exposure at different time points 
 





*Repeated Measures ANOVA 
**T-test 
 
Table 3 shows TAC of saliva in the two groups 
at different time points. ANOVA revealed a 
significant increase in TAC of saliva in the 
passive smoker group (p<0.009) at three 
different   time   points   compared   to   the non- 
smoker group (p<0.0001). T-test indicated a 
significant increase in TAC of saliva at baseline 
(p<0.024) and day 15 (p<0.01) in the passive 
smoker group compared to the control group. 
But,  at  day  30,  the  difference  in  this   regard 
 (intragroup) 
Passive smoker 1723.604 (148.9893) 964.282 (65.8632) 880.1311 (39.9747) 0.0001 
Non-smoker 1939.462 (213.8529) 769.3984 (63.9050) 815.6989 (62.30618) 0.6 
P** 0.38 0.0001 0.086  
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between  the  two  groups  was   not  statistically significant (p=0.897). 
 
Table 3. The mean and standard deviation of TAC of saliva in rats in the two groups of passive smoker and 
non-smoker at different time points 
 










Based on the obtained results, serum cotinine 
concentration in the exposure group at day 15 
and 30 was significantly higher than in the 
control group. The difference in this regard 
between the two groups at baseline was not 
significant; which indicates the reliability of 
testing. In a study by Polidori et al. in 2003 all 
participants experienced a reduction in their 
cotinine serum concentration after cigarette 
smoking cessation; this finding is in accord with 
our study results (13). Based on the obtained 
results, TAC of serum and saliva in animals of 
the passive smoker group significantly increased 
compared to the control samples. However, the 
increase in TAC values at day 30 was not 
significant in the exposure group. At baseline, 
the difference in TAC of saliva between the two 
groups was significant but no such  difference 
was noted in serum TAC between the two 
groups. It seems that after an increase in TAC of 
serum and saliva at day 15, rats’ immune system 
was able to somehow compensate the adverse 
effects of passive smoking and reduce the TAC 
of serum and saliva. Also, it seems that if this 
trend had continued, greater reduction in TAC of 
saliva and serum would have been occurred in 
the passive smoker group. 
In a study by Charalabopoulos et al. in 2005 no 
significant differences were found between 
smokers and non-smokers in TAC of saliva (20). 
However, in the mentioned study, TAC of 
plasma in smokers before and after smoking was 
greater than in control subjects (20). There are 
evidence indicating that young smokers produce 
compensatory blood levels of glutathione after 
the inhalation of cigarette smoke that effectively 
prevent peroxidation of plasma lipids (in  
contrast to old smokers)(21). Thus, young 
smokers may be able to confront the oxidative 
stress caused by smoking via increasing the 
production of glutathione or its release into the 
plasma. Aside from the increased production of 
glutathione, this increase may be due to the 
release of intracellular antioxidants into the 
bloodstream (plasma). 
Despite having an innate tendency for oxidative 
invasion, body has a natural anti-oxidant system 
in which a series of enzymes, vitamins and other 
antioxidants act as regulatory mechanisms. The 
superoxide dismutase and glutathione peroxide 
enzymes are at the frontline of immune system 
against reactive oxygen species and are usually 
referred to as primary antioxidants (22). 
Increased TAC of serum and saliva in passive 
smoker rats in the present study may be 
attributed to the activation of their immune 
system against the passive cigarette smoke. TAC 
of saliva participates in salivary antioxidant 
enzymatic mechanisms like glutathione 
peroxidase (23) and is also associated with 
presence of different antioxidants such as urate 
and ascorbate (24). These factors can prevent the 
effects of radicals produced following oxidative 
stress in the saliva and plasma (25) and salivary 
proteins like glucoproteins (26). There are some 
food products that may  play  a role in TAC     of 
    (intragroup) 
Passive smoker 743.052 (110.003) 772.8556 (190.579) 732.4253 (93.1909) 0.009 
Non-smoker 628.8056 (42.1389) 527.9102 (80.1925) 707.5218 (125.2086) 0.0001 
P** 0.024 0.01 0.897  
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saliva. Polyphenol and its metabolites such as 
flavonoids, ligin and tannin are among these 
compounds (27). These factors can all affect the 
TAC of saliva. On the other hand, increased 
production of reactive oxygen species following 
cigarette smoke exposure in some cases may 
overcome the immune system and cause 
oxidative damage to select proteins, lipids and 
DNA (28, 29). 
A wide range of oxidants and free radicals are 
released following tobacco use. In addition to 
oxidative injury, these factors can cause 
pulmonary conditions, cardiovascular diseases 
and cancer in the smoker individual (30). 
Although the mechanisms of involvement in 
smoking-related pathologies are still a matter of 
debate, it appears that free radicals play a critical 
role in the pathogenesis of these conditions (30). 
Free radicals are capable of inducing oxidative 
stress directly or indirectly. Bolisetty et al. in 
2002 reported that infants exposed to free 
radicals had less antioxidant vitamins in 
comparison to control subjects (31). 
Furthermore, oxidative stress is a consequence 
of low levels of antioxidant vitamins in passive 
smokers. It has been reported that in infants 
exposed to passive smoke, some products of the 
antioxidant system in the body becomedefective 
(29). However, possible injury caused by free 
radicals is minimized via the antioxidant system. 
Chelchowska et al. in 2005 reported that TAC 
significantly decreased in blood samples of 
infants  of  smoker  mothers  (32). Also, Fayol et 
 
al. in 2005 showed that TAC values decreased in 
blood samples of infants of passive smoker 
mothers whilethese changes were observed  in 
the infants of active smoker mothers (33). Based 
on the results of Aycicek and Ipek in 2008, TAC 
of blood in passive and active smokers was 
significantly lower than that of control subjects 
(30). Also, Aycicek et al. in 2005 revealed that 
plasma TAC in passive smokers was 
significantly lower than control subjects (12). 
These findings are in contrast to our obtained 
results. Despite the fact that the nicotine level as 
an indicator of passive smoking has high 
specificity, its biologic half life in bloodstream is 
short (20-30 min). Thus, due to the importance  
of time in collection of samples after smoking, it 
cannot be used for research purposes. However, 
the clinical half life of cotinine, a nicotine 
metabolite, is longer (about 30 h) and thus, 
measurement of cotinine level is a good marker 





Based on the obtained results, changes in TAC 
of serum and saliva in rats due to exposure to 
cigarette smoke were compensated by their 
immune system. However, further investigations 
are still required in this respect. Due to various 
adverse effects, passive smoking should be 
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